Vijay Viswanathan

A Pharmaceutical Paradigm for Cardiovascular Composite Risk Assessment Using Novel Radiogenomics Risk Predictors in Precision Explainable Artificial Intelligence Framework: Clinical Trial Tool.

Laura E. Mantella, E. Isenovic, K. Paraskevas, 2023, Frontiers in bioscience.

Polygenic Risk Score for Cardiovascular Diseases in Artificial Intelligence Paradigm: A Review

M. Kalra, E. Isenovic, K. Paraskevas, 2023, Journal of Korean medical science.

Artificial intelligence for cardiovascular disease risk assessment in personalised framework: a scoping review

Laura E. Mantella, E. Isenovic, D. Mikhailidis, 2024, EClinicalMedicine.

UltraAIGenomics: Artificial Intelligence-Based Cardiovascular Disease Risk Assessment by Fusion of Ultrasound-Based Radiomics and Genomics Features for Preventive, Personalized and Precision Medicine: A Narrative Review

Laura E. Mantella, E. Isenovic, K. Paraskevas, 2024, Reviews in cardiovascular medicine.